Co-Founder and Chairman
Since being diagnosed with multiple myeloma in 2002, Mr Del Col has directed his attention to creating an effective national platform to address the needs of the Canadian myeloma community. In 2004 he founded the Myeloma Montreal Support Network, and in 2005 he co-founded Myeloma Canada. Mr Del Col has focused his efforts on establishing the organization as the voice of the Canadian myeloma community, first as President of the Board of Directors, then as Executive Director from 2010 to 2013, and now as Chairman of the Board. More recently he co-founded the Myeloma Canada Research Network (MCRN), a sister organization to Myeloma Canada, to accelerate the advancement of Canadian myeloma research. Drawing upon his scientific and pharmaceutical background, he works closely with Canada’s leading myeloma researchers, investigators, clinicians, and pharmaceutical companies to drive research focused on optimizing patient outcomes.
Mr Del Col holds a Bachelor of Science in Pharmacy degree from the University of Toronto and a Master in Business Administration from York University. Throughout his extensive career, Mr Del Col has gained knowledge and experience not only as a Community Pharmacist, but also as a Financial Analyst for a multinational pharmaceutical company and National Director of Sales and Marketing for a global health and beauty consumer products corporation.
In addition to his ongoing responsibilities with Myeloma Canada and the Myeloma Canada Research Network, Mr Del Col works part time in a community pharmacy, and serves as the hematology patient representative for the Canadian Cancer Trials Group (CCTG) and as a reviewer for their Clinical Trials Committee. He is also a member of the Global Myeloma Action Network, serves on the Board of Directors of the International Myeloma Foundation, and participates in both national and international advisory boards.